MedTrace Logo

Detection of Group A β-Hemolytic Streptococci in Oral Samples

NCT05223634 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-02-04

No results posted yet for this study

Summary

This prospective, sample collection study will assess different oral and/or nasal sample types collected from patients suspected of suffering from GABHS pharyngitis to conduct research and development on innovative GABHS detection methods specific for each sample type.

Conditions

  • Group A β-Hemolytic Streptococci

Interventions

OTHER

Collection of oral and/or nasal samples

Collection of oral and/or nasal samples after SOC test performed

Sponsors & Collaborators

  • Hero Scientific

    lead INDUSTRY

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-18
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05223634 on ClinicalTrials.gov